Member Exclusive

Cell therapy weekly: MSCs show promise to treat rare pediatric heart condition

This week: Longeveron treats first patient with MSCs, Duchenne muscular dystrophy improved in mouse model and new funding for development of synthetic ‘gene circuits.

Go to the profile of RegMedNet
Mar 01, 2018

Please sign in or register for FREE

Register to RegMedNet

RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.


No comments yet.